Cluster Headaches Symptoms, Treatment and Prevention
Cluster head aches: Cluster head aches are not so common like migraine. However it is not uncommon. Men are more prone for the cluster attacks ... Read More
Mechanism of Human Respiration
Mechanism of Human Respiration Oxygen is required by the cells for oxidising the food and to release the energy. The cells cannot utilise the oxygen ... Read More
Circulatory System : List of Arteries and Veins
The Circulatory System consists of Heart and Blood Vessels Types of Blood Vessels: The circulatory system consists of blood vessels that are of two types ... Read More
FDA grants emergency use authorization to Janssen COVID-19 vaccine
The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson's ... Read More
Humacyte to merge with Alpha Healthcare Acquisition Corp in $1.1bn deal to advance regenerative medicine
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare Acquisition Corp. (AHAC), a blank check company. ... Read More
FDA approves G1 Therapeutics’ Cosela for reducing chemotherapy-induced bone marrow suppression
G1 Therapeutics has achieved a significant milestone with the recent U.S. Food and Drug Administration (FDA) approval of Cosela (trilaciclib), a pioneering treatment designed to ... Read More
Targovax’s ONCOS-102 receives FDA fast track designation for malignant pleural mesothelioma treatment
In a significant development for cancer treatment, Targovax, a Norwegian biotech firm specializing in immune-oncology, has announced that its lead candidate, ONCOS-102, has been granted ... Read More
Sandoz to acquire GSK’s cephalosporin antibiotics business for $500m
Sandoz, a division of the Swiss pharmaceutical giant Novartis, has finalized a deal to acquire the cephalosporin antibiotics business from GSK (GlaxoSmithKline) for up to ... Read More
AstraZeneca’s Forxiga wins approval in China for heart failure treatment
AstraZeneca has announced that its drug, Forxiga (dapagliflozin), has received approval from the Chinese National Medical Products Administration (NMPA) to reduce the risk of cardiovascular ... Read More
DJO expands foot and ankle surgery portfolio with acquisition of Trilliant Surgical
DJO, a leading provider of medical technologies based in Texas, has strategically enhanced its presence in the foot and ankle surgery market with the acquisition ... Read More